BCTX:Briacell Therapeutics Corp (New) - Stock Price Quote and Dividend Data

BCTX STOCK PRICE LATEST CLOSE

$4.01

EXCHANGE

NASDAQ

BCTX

Briacell Therapeutics Corp (New) Dividend Information

Projected 12 Month Dividend Yield0.00%
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Payment TypeN/A
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
BCTX

Briacell Therapeutics Corp (New) Stock Price Information

BCTX Stock Price Latest Close$4.01
52-Week Low/High Stock Price$3.00 - $42.75
Percent Held by Institutions6.70%
Revenue$0
Net Income$-17,883,421
Cash Flow$-27,915,084
EPS-2.33%
Market Cap$14,873,090
Issue TypeCommon, ordinary, ADR, etc.
PE Ratio2
PE Ratio to Industry119%
Debt-Equity Ratio0.00%
Debt-Equity to Industry2.03%
Total Return Last 12 Months-90.21%
Total Return Last 3 Years-97.75%
Total Return Last 5 Years-96.58%
Latest Trade DateApr. 10, 2025
BCTX

Briacell Therapeutics Corp (New) Annual Stock Dividends

No Data available for Payment History.

BCTX

Briacell Therapeutics Corp (New) Dividend Payment History

No dividends retrieved for BCTX
BCTX

Briacell Therapeutics Corp (New) Other Dividend Details

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient's immune system to specifically kill cancer cells without harming other cells. Co. is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer.

Web Sitewww.briacell.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Briacell Therapeutics Corp (New) Dividend Stock News and Updates

Apr. 05, 2025BCTX STOCK PRICE INCREASE: Briacell Therapeutics Corp (New) on 04-05-2025 increased stock price > 10% from $3.50 to $3.94

Mar. 20, 2025BCTX STOCK PRICE INCREASE: Briacell Therapeutics Corp (New) on 03-20-2025 increased stock price > 10% from $3.88 to $4.27

Mar. 15, 2025BCTX STOCK PRICE INCREASE: Briacell Therapeutics Corp (New) on 03-15-2025 increased stock price > 10% from $3.45 to $3.84

Mar. 04, 2025BCTX STOCK PRICE DECREASE: Briacell Therapeutics Corp (New) on 03-04-2025 decreased stock price > 10% from $3.67 to $3.25

Feb. 22, 2025BCTX STOCK PRICE DECREASE: Briacell Therapeutics Corp (New) on 02-22-2025 decreased stock price > 10% from $5.07 to $4.42

Feb. 19, 2025BCTX STOCK PRICE INCREASE: Briacell Therapeutics Corp (New) on 02-19-2025 increased stock price > 10% from $4.35 to $5.09

Feb. 15, 2025BCTX STOCK PRICE INCREASE: Briacell Therapeutics Corp (New) on 02-15-2025 increased stock price > 10% from $3.83 to $4.35

Feb. 13, 2025BCTX STOCK PRICE INCREASE: Briacell Therapeutics Corp (New) on 02-13-2025 increased stock price > 10% from $3.43 to $3.78

Feb. 05, 2025BCTX STOCK PRICE DECREASE: Briacell Therapeutics Corp (New) on 02-05-2025 decreased stock price > 10% from $5.04 to $4.10

Jan. 30, 2025BCTX STOCK PRICE INCREASE: Briacell Therapeutics Corp (New) on 01-30-2025 increased stock price > 10% from $0.37 to $5.90

More Briacell Therapeutics Corp (New) Dividend News
Pharmaceuticals Dividend Stock News and Updates

Apr. 11, 2025NTHI STOCK PRICE DECREASE: NeOnc Technologies Holdings Inc on 04-11-2025 decreased stock price > 10% from $10.00 to $9.00

Apr. 11, 2025SION STOCK PRICE DECREASE: Sionna Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $8.88 to $7.66

Apr. 11, 2025MTSR STOCK PRICE DECREASE: Metsera Inc on 04-11-2025 decreased stock price > 10% from $15.27 to $13.08

Apr. 11, 2025CYTOF STOCK PRICE DECREASE: Altamira Therapeutics Ltd on 04-11-2025 decreased stock price > 10% from $0.09 to $0.06

Apr. 11, 2025DWTX STOCK PRICE DECREASE: Dogwood Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $3.30 to $2.94

Apr. 11, 2025TRVN STOCK PRICE DECREASE: Com Par $0.001/Trevena Inc on 04-11-2025 decreased stock price > 10% from $1.36 to $1.20

Apr. 11, 2025OSTX STOCK PRICE DECREASE: OS Therapies Inc on 04-11-2025 decreased stock price > 10% from $1.34 to $1.12

Apr. 11, 2025RGBPP STOCK PRICE DECREASE: Pfd Ser A (New)/Regen BioPharma Inc on 04-11-2025 decreased stock price > 10% from $0.06 to $0.05

Apr. 11, 2025ALMS STOCK PRICE DECREASE: Alumis Inc on 04-11-2025 decreased stock price > 10% from $8.04 to $6.83

Apr. 11, 2025CTNM STOCK PRICE DECREASE: Cl A/Contineum Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $4.62 to $4.13

More Pharmaceuticals Dividend News
X
Search Dividend Investor